Prognostic value of receptor status change following neoadjuvant chemotherapy in locally advanced breast cancer

• Published in: Cancer treatment communications Vol. 4; pp. 89 - 95
• Main Authors: Ozmen, Vahit, Atasoy, Ajlan, Bozdogan, Atilla, Dincer, Maktav, Eralp, Yesim, Tuzlali, Sitki
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 2015
• Subjects: Disconcordance; Hematology, Oncology and Palliative Medicine; Hormone receptor; Immunohistochemistry; Neoadjuvant chemotherapy; Receptor status; Survival; Neoadjuvant chemotherapy; Immunohistochemistry; Receptor status; Hormone receptor; Disconcordance; Survival

Abstract Introduction The effect of neoadjuvant chemotherapy (NAC) on the expression of receptor status in locally advanced breast cancer (LABC) is still under investigation. Aims of this study are to evaluate changes in hormone receptor (HR) and HER-2 status post-NAC and correlation with survival....